Last Updated : May 13, 2004
Details
FilesGeneric Name:
Miglustat
Project Status:
Complete
Therapeutic Area:
Gaucher disease
Manufacturer:
Actelion Pharmaceuticals Canada Inc.
Brand Name:
Zavesca
Project Line:
Reimbursement Review
Project Number:
SR0012-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Gaucher disease
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list.
Files
Last Updated : May 13, 2004